Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19

Here, we advocate a highly favourable opportunity for the treatment of COVID-19 disease by repurposing a long-serving medical agent with an excellent history of clinical use, namely heparin. Heparin is best known as an anticoagulant, but it also exhibits direct antiviral activity against many envelo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Med (Lond)
Hauptverfasser: Conzelmann, Carina, Müller, Janis A, Perkhofer, Lukas, Sparrer, Konstantin MJ, Zelikin, Alexander N, Münch, Jan, Kleger, Alexander
Format: Artigo
Sprache:Inglês
Veröffentlicht: Royal College of Physicians 2020
Schlagworte:
COVID-19 rapid report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7687307/
https://ncbi.nlm.nih.gov/pubmed/32863274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmed.2020-0351
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge